H057

· Shanghai Huilun Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H057, covering 2025-05-09 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis [Phase 2]

See pricing